Brief

Medical Device Company Body Vision Raises $20 Million

Body Vision develops intra-body navigation technology to assist early lung cancer diagnostics and treatment

Medical device company Body Vision Medical Ltd. has completed a $20 million series C funding round, the company announced Wednesday. Body Vision intends to use the funds to streamline the commercialization and manufacturing of its disposable lung navigation catheter, which received U.S. Food and Drug Administration (FDA) approval in May.

 

Founded in 2014 and based in central Israeli town Ramat Hasharon, Body Vision develops intra-body navigation technology designed to assist early lung cancer diagnostics and treatment. The company has raised $34.5 million to date, according to Pitchbook data.

Lung CT (illustration). Photo: Shutterstock